Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Pluri Inc. is a biotechnology company specializing in proprietary 3D cell expansion technology for scalable solutions across healthcare, food, and agriculture. Its core activities include developing cell therapies, regenerative medicine, cultivated food products, and contract manufacturing services. The company leverages its innovative platform for cell-based therapeutics, food tech, and AgTech, serving global markets with a focus on sustainability, cost-efficiency, and advanced bioprocessing.
This description was generated via AI from an annual report. Updated about 1 year ago.